Criteria for histopathologic diagnosis of aortic disease Consensus Statement from the SIAPEC-IAP Study Group of "Cardiovascular Pathology" in collaboration with the Association for Italian Cardiovascular Pathology

Pathologica

Volumn 104, Issue 1, 2012, Pages 1-33

  Leone, O ^a   Agozzino, L ^b   Angelini, A ^c   Bartoloni, G ^d   Basso, C ^c   Caruso, G ^e   D'Amati, G ^f   Pucci, A ^g   Thiene, G ^c   Gallo, P ^f  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Aortic degenerative pathology; Aortic inflammation; Aortic tumours; Aortitis; Atherosclerosis

Indexed keywords

AORTA; AORTA DISEASE; ARTICLE; CONSENSUS; CONSENSUS DEVELOPMENT; COOPERATION; ITALY; PATHOLOGY; STANDARD; VASCULAR TUMOR; VASCULITIS;

AORTA; AORTIC DISEASES; CONSENSUS; COOPERATIVE BEHAVIOR; ITALY; PATHOLOGY, CLINICAL; VASCULAR NEOPLASMS; VASCULITIS;

EID: 84862751391     PISSN: 00312983     EISSN: 1591951X     Source Type: Journal    
DOI: None     Document Type: Article

References (211)

1. El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol 2009;6:771-86.
2. Ruddy JM, Jones JA, Spinale FG, et al. Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg 2008;136:1123-30.
3. Karnik SK, Brooke BS, Bayes-Genis A, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003;130:411-23. (Pubitemid 36175937)
4. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol 2007;213:565-73. (Pubitemid 350058247)
5. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619-47. (Pubitemid 46697919)
6. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res 1969;25:677-86.
7. Wolinsky H. Comparison of medial growth of human thoracic and abdominal aortas. Circ Res 1970;27:531-8.
8. Kim BS, Nikolovski J, Bonadio J, et al. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 1999;17:979-83. (Pubitemid 29474853)
9. Halloran BG, Davis VA, McManus BM, et al. Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 1995;59:17-22.
10. Halloran BG, Baxter BT. Pathogenesis of aneurysms. Semin Vasc Surg 1995;8:85-92.
11. Goumans MJ, Liu Z, ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009;19:116-27.
12. Gallo P, di Gioia C. Patologia dei vasi. In: Gallo P, d'Amati G, eds. Anatomia Patologica - La sistematica. Torino: Utet 2008.
13. Atherosclerosis. In: Silver MD, Gotlieb AI, Schoen FJ, eds. Cardiovascular Pathology. Philadelphia, PA: Lippincott 2002.
14. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
15. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26. (Pubitemid 29054847)
16. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010;7:77-86.
17. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868- 74. (Pubitemid 36019640)
18. Corti R, Hutter R, Badimon JJ, et al. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 2004;17:35-44. (Pubitemid 39069460)
19. Ridker PM, Silvertown JD. Inflammation, C-reactive protein levels and atherothrombosis. J Periodontol 2008;79:1544-51.
20. Glass CK, Witztum JL. Atherosclerosis the road ahead. Cell 2001;104:503-16.
21. Richter B, Niessner A, Penka M, et al. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost 2005;94:1306-11. (Pubitemid 41819631)
22. Roberts CK, Ng C, Hama S, et al. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol 2006;101:1727-32. (Pubitemid 44904495)
23. Wierda RJ, Geutskens SB, Jukema JW, et al. Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 2010;14:1225-40.
24. Turunen MP, Aavik E, Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 2009;1790:886-91.
25. Back M, Ketelhuth DF, Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010;52:410-28.
26. Reddy KJ, Singh M, Bangit JR, et al. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med (Hagerstown) 2010;11:633-47.
27. Nofer JR, Brodde MF, Kehrel BE. High density lipoproteins (HDL), platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol 2010;37:726-35.
28. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462-78.
29. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-74.
30. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75. (Pubitemid 30262927)
31. Van Dijk RA, Virmani R, von der Thusen JH, et al. The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region. Atherosclerosis 2010;210:100-6.
32. Movat HZ, More RH, Haust MD. The diffuse intimal thickening of the human aorta with aging. Am J Pathol 1958;34:1023-31.
33. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 1993;13:1291-8.
34. Stary HC. Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutrition 2000;72:1297S-306S.
35. McGill Jr HC. Fatty streaks in the coronary arteries and aorta. Lab Invest 1968;18:560-4.
36. Stary HC. Natural history and histological classification of atherosclerotic lesions an update. Arterioscler Thromb Vasc Biol 2000;20:1177-8. (Pubitemid 30262913)
37. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991;139:1119-29.
38. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003;100:4736-41. (Pubitemid 36457799)
39. Khurana R, Zhuang Z, Bhardwaj S, et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 2004;110:2436-43. (Pubitemid 39407351)
40. van der Wal AC, Becker AE. Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability. Cardiovasc Res 1999;41:334-44. (Pubitemid 29087330)
41. Davies MJ, Richardson P, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaque: role of extracellular lipid, macrophages and smooth muscle cell content. Br Heart J 1993;69:377-81. (Pubitemid 23171108)
42. Kolodgie FD, Burke AP, Farb A, et al. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 2002;22:1642-8.
43. Moreno PR, Purushothaman R, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesion of human aorta. Implication for plaque vulnerability. Circulation 2004;110:2032-8. (Pubitemid 39331918)
44. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Throm Vasc Biol 2005;25:2054-61. (Pubitemid 41416300)
45. Schrijvers DM, De Meyer GRY, Herman AG, et al. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007;73:470-80. (Pubitemid 46073944)
46. Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:13-8.
47. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995;75:3B-11B.
48. Sundt TM. Intramural hematoma and penetrating atherosclerotic ulcer of the aorta. Ann Thorac Surg 2007;83:S835-41. (Pubitemid 46135503)
49. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365:1577-89. (Pubitemid 40615407)
50. Urbonavicius S, Urbonaviciene G, Honore B, et al. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture - a systematic review. Eur J Vasc Endovasc Surg 2008;36:273-80.
51. Elefteririades JA. Thoracic aortic aneurysm: reading the enemy's playbook. Curr Probl Cardiol 2008;33:203-77.
52. Moreno PR, Purushothaman KR, Fuster V, et al. Intimo-medial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 2002;105:2504-11. (Pubitemid 34568972)
53. Rutherford RB. Atheroembolism and microthromboembolic syndromes. In: Jeffrey LK, ed. Vascular Surgery, fifth edition. Philadelphia, PA: Saunders 2000, pp. 836-45.
54. Kealy WF. Atheroembolism. J Clin Pathol 1978;31:984-9. (Pubitemid 9055254)
55. Gornik HL, Creager MA. Aortitis. Circulation 2008;117:3039-51.
56. Foote EA, Poster RG, Greenfield RA, et al. Infectious aortitis. Curr Treat Opt Cardiovasc Med 2005;7:89-97. (Pubitemid 41630929)
57. Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review. Clin Cardiol 2009;32:488-90.
58. Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 2006;30:1150-8. (Pubitemid 44299348)
59. Pacini D, Leone O, Turci S, et al. Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg 2008;86:1518-23.
60. Tavora F, Burke A. Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology 2006;38:302-8. (Pubitemid 44266626)
61. Rojo-Leyva F, Ratliff NB, Cosgrove DM 3rd, et al. Study of 52 patients with idiopathic aortitis from a cohort of 1.204 surgical cases. Arthritis Rheum 2000;43:901-07.
62. Homme JL, Aubry M-C, Tazelaar HD, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 2006;30:1159-68. (Pubitemid 44299349)
63. Nesi G, Anichini C, Tozzini S, et al. Pathology of the thoracic aorta: a morphologic review of 338 surgical specimens over a 7-year period. Cardiovasc Pathol 2009;18:134-9.
64. Virmani R, Burke AP. Nonatherosclerotic diseases of the aorta and miscellaneous diseases of the main pulmonary arteries and large veins. In: Silver MD, Gotlieb AI, Schoen FJ, eds. Cardiovascular Pathology. Philadelphia, PA: Churchill Livingstone 2001, pp. 119-37.
65. Lee I, Park S, Hwang I, et al. Cardiac Behcet disease presenting as aortic valvulitis/aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases. Am J Surg Pathol 2008;32:390-8. (Pubitemid 351398930)
66. Gravallese EM, Corson JM, Coblyn JS, et al. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine (Baltimore) 1989;68:95-106. (Pubitemid 19088085)
67. Reimer KA, Rodgers RF, Oyasu R. Rheumatoid arhritis with rheumatoid heart disease and granulomatous aortitis. JAMA 1976;235:2510-2.
68. Stone JH, Khosroshahi A, Hilgenberg A, et al. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 2009;60:3139-45.
69. Stone JR, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken) 2010;62:316-22.
70. Burke AP, Tavora F, Narula N, et al. Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histological classification. Hum Pathol 2008;39:514-26.
71. Walker DI, Bloor K, Williams G, et al. Inflammatory aneurysms of the abdominal aorta. Br J Surg 1972;59:609-14.
72. Roth M, Lemke P, Bohle RM, et al. Inflammatory aneurysm of the ascending thoracic aorta. J Thorac Cardiovasc Surg 2002;123:822-4. (Pubitemid 34535097)
73. Yoshida M, Mukohara N, Honda T, et al. Inflammatory aneurysm of the ascending aorta: report of a case. Surg Today 2007;37:794-7. (Pubitemid 47312518)
74. Rasmussen TE, Hallett JW Jr. Inflammatory aortic aneurysms. A clinical review with perspectives in pathogenesis. Ann Surg 1997;225:155-64. (Pubitemid 27083775)
75. Meier P, Vogt B, Blanc E. Rethinking the triggering inflammatory processes of chronic periaortitis. Nephron Exp Nephrol 2007;105:e17-23. (Pubitemid 46006573)
76. Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms. Immunophenotypic analisys suggesting an immunemediated response. Am J Pathol 1990;137:1199-213.
77. Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 2005;17:34-40. (Pubitemid 40075645)
78. Gasparovic H, Nascimben L, Kindelberger DW, et al. Idiopathic inflammatory aneurysms of the ascending aorta. Ann Thorac Surg 2005;80:1912-4. (Pubitemid 41464330)
79. Parums DV. The spectrum of chronic periaortitis. Histopathology 1990;16:423-31. (Pubitemid 20153968)
80. Diseases of the aorta. In: Sheppard MN, Davies MJ, eds. Practical Cardiovascular Pathology. London: Tenon & Poler Colour Scanning 1998, pp. 171-90.
81. Calabrese F, van der Wal AC, Levi M. Infection and inflammation in the cardiovascular system. Cardiovasc Res 2003;60:1-4. (Pubitemid 38373470)
82. Chesebro BB, Blessing E, Kuo C-C, et al. Nitric oxide synthase plays a role in Chlamydia pneumonite-induced atherosclerosis. Cardiovasc Res 2003;60:170-4. (Pubitemid 38373489)
83. De Kleinijn D, Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc Res 2003;60:58-67. (Pubitemid 38373476)
84. de Boer OJ, Becker AE, van der Wal AC. T lymphocytes in atherogenesis- functional aspects and antigenic repertoire. Cardiovasc Res 2003;60:78-86. (Pubitemid 38373478)
85. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium 2006;13:423-429. (Pubitemid 44941973)
86. Bacon PA. Endothelial cell disfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol 2005;17:49-55. (Pubitemid 40075647)
87. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiopogy of vascular disorders. Blood 1998;91:3527-61. (Pubitemid 28225719)
88. Marsik C, Graninger M, Mackman N, et al. Effects of enalapril on disseminated intravascular thrombin formation during systemic inflammation. Cardiovasc Res 2003;60:131-5. (Pubitemid 38373483)
89. Defawe O, Colige A, Lambert CA, et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to atero-occlusive abdominal aortas. Cardiovasc Res 2003;60:205-13. (Pubitemid 38373493)
90. Peters K, Unger RE, Brunner J, et al. The molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003;60:49-57. (Pubitemid 38373475)
91. Prishchep O, Ma-Kruoa W, Younge BR, et al. Vessel-specific tolllike receptor profiles in human medium and large arteries. Circulation 2008;118:1276-84.
92. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol 1952;22:777-90.
93. Morgan MD, Savane CO. Vasculitis in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2005;19:215-33.
94. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003;349:160-9. (Pubitemid 36818787)
95. Hoffman GS. Large-vessel vasculitis: unresolved issues. Arthritis Rheum 2003;48:2406-14. (Pubitemid 37129417)
96. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. (Pubitemid 34212626)
97. Hildebrandt HA, Goessl M, Mannheim D, et al. Differential distribution of vasa vasorum in different vascular beds in humans. Atherosclerosis 2008;199:47-54. (Pubitemid 351842690)
98. Wagner AD, Bjorsson J, Bartley GB, et al. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissueinfiltrating cells and are located distant from the site of pathology. Am J Pathol 1996;148:1925-33. (Pubitemid 26170517)
99. Weyand CM, Ma-Krupa W, Pryshchep O, et al. Vascular dendritic cells in giant cell arteritis. Ann NY Acad Sci 2005;1062:195-208.
100. Ma-Krupa W, Jeon MS, Spoerl S, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004;199:173-83. (Pubitemid 38129698)
101. Binder CJ, Chang MK, Shaw PX, et al. Innate and acquired immunity in atherogenesis. Nat Med 2002;8:1218-26. (Pubitemid 35373552)
102. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
103. Galle J. Atherosclerosis and arteritis: implications for therapy of cardiovascular disease. Herz 2004;29:4-11. (Pubitemid 38268585)
104. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81.
105. Binder CJ, Shaw PX, Chang MK, et al. The role of natural antibodies in atherogenesis. J Lipid Res 2005;46:1353-63. (Pubitemid 43109798)
106. Ramshaw AL, Parums DV. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 1990;17:543-52.
107. van der Wal AC, Becker AE, Das PK. Medial thinning and atherosclerosis- evidence for involvement of a local inflammatory effect. Atherosclerosis 1993;103:55-64. (Pubitemid 23313139)
108. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009;27:165-97.
109. Liang KP, Chowdhary VR, Michet CJ, et al. Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 2009;36:2290-7.
110. Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol 1970;23:681-9.
111. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006;367:241-51. (Pubitemid 43107670)
112. Haug ES, Skomsvoll JF, Jacobsen G, et al. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg 2003;38:492-7. (Pubitemid 41123211)
113. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003;114:454-62. (Pubitemid 36515107)
114. Meier P, Rotman S, Blanc E, et al. Retroperitoneal fibrosis, a true inflammatory disease: new insights in an old entità. In: Pitzer JA, ed. Progress in inflammation research. New York: Nova Publishers 2005, pp. 3-45.
115. Guo DC, Papke CL, He R, et al. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 2006;1085:339-52. (Pubitemid 47091985)
116. Thompson RW, Geraghty PJ, Lee GK. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr Probl Surg 2002;39:110-230.
117. Michel JB. Acquired abdominal aortic aneurysm. Nephrol Dial Transplant 1998;13(Suppl 4):20-4.
118. Beckman EN. Plasma cell infiltrates in atherosclerotic abdominal aortic aneurysm. Am J Clin Pathol 1986;85:21-4. (Pubitemid 16166035)
119. Lindholt JS, Shi GP. Chronic inflammation, immune response and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2006;31:453-63.
120. Numano F. Vasa vasortis, vasculitis and atherosclerosis. Int J Cardiol 2000;75(Suppl 1):S1-8.
121. Herron GS, Unemori E, Wong M, et al. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysmus. Artherioscler Thromb Vasc Biol 1991;11:1667-77.
122. Michel JB, Thaunat O, Houard X, et al. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007;27:1259-68. (Pubitemid 46809413)
123. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26:987-94. (Pubitemid 43732102)
124. Schonbeck U, Sukohova GK, Gerdes N, et al. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysms. Am J Pathol 2002;161:499-506. (Pubitemid 36142159)
125. Hirose H, Tilson MD. Abdominal aortic aneurysm a san autoimmune disease. Ann NY Acad Sci 2001;947:416-8. (Pubitemid 34059949)
126. He R, Guo DC, Estreta AL, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg 2006;131:671-8.
127. Tang PC, Yakimov AO, Teesdale MA, et al. Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodelling and intimal expansion of ascending thoracic aneurysms. FASEB J 2005;19:1528-30. (Pubitemid 41279020)
128. He R, Guo DC, Sun W, et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms and sporadic aneurysms. J Thorac Cardiovasc Surg 2008;136:922-9.
129. Schulte S, Sukhova GK, Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am J Pathol 2008;172:1500-8. (Pubitemid 351793344)
130. Krebs P, Scandella E, Bolinger B, et al. Chronic immune reactivity against persisting microbial antigen in the vasculature exacerbates atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 2007;27:2206-13. (Pubitemid 350287251)
131. Gregory AK, Yin NX, Capella J, et al. Features of autoimmunity in the abdominal aortic aneurysm. Arch Surg 1996;131:85-8. (Pubitemid 26015413)
132. Moos MP, John N, Grabner R, et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2386-91. (Pubitemid 41552659)
133. Freeman AF, Crawford SE, Cornwall ML, et al. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2005;26:578-84. (Pubitemid 43015790)
134. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl 1992;7:11-7.
135. Ma-Krupa W, Kwan M, Goronzy JJ, et al. Toll-like receptors in giant cell arteritis. Clin Immunol 2005;115:38-46. (Pubitemid 40616167)
136. Thaunat O, Field AC, Dai J, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005;102:14723-8. (Pubitemid 41457123)
137. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol 2006;27:441-5. (Pubitemid 44354310)
138. Zhao L, Moos MP, Grabner R, et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004;10:966-73. (Pubitemid 39273738)
139. Baek HJ, Shin KC, Lee YJ, et al. Takayasu's arteritis concurrent with Marfan syndrome-a case report. Angiology 2000;51:435-9. (Pubitemid 30317035)
140. Martinez-Taboada V, Brack A, Hunder GG, et al. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996;23:1011-4. (Pubitemid 26196090)
141. Brack A, Geisler A, Martinez-Taboada VM, et al. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;3:530-43. (Pubitemid 127499166)
142. Weyand CM, Younge BR, Goronzy JJ. T cells in arteritis and atherosclerosis. Curr Opinion Lipidol 2008;19:469-77.
143. Erdheim J. Medionecrosis aortae idiopathica (cystica). Arch Pathol Anat Physiol Klin Med 1929;273, 454-79.
144. Erdheim J. Medionecrosis aortae idiopathica cystica. Arch Pathol Anat Physiol Klin Med 1930, 276:187-229.
145. Gsell O. Wandnekrosen der Aorta als selbständige Erkrankung und ihre Beziehung zur Spontanruptur. Arch Pathol Anat Physiol Klin Med 1928;270:1-36.
146. Gore I, Seiwert VJ. Dissecting aneurysm of the aorta; pathological aspects; an analysis of eighty-five fatal cases. AMA Arch Pathol 1952;53:121-41.
147. Hirst AE, Gore I. Is cystic medionecrosis the cause of dissecting aortic aneurysm? Circulation 1976;53:915-6.
148. Carlson RG, Lillehei CW, Edwards JE. Cystic medial necrosis of the ascending aorta in relation to age and hypertension. Am J Cardiol 1970;25:411-9.
149. Schlatmann TJM, Becker AE. Histologic changes in the normal aging aorta. Am J Cardiol 1977;39:13-20.
150. Schlatmann TJM, Becker AE. Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. Am Cardiol 1977;39:21-6. (Pubitemid 8022420)
151. Edwards JE. Manifestations of acquired and congenital diseases of the aorta. Curr Probl Cardiol 1979;3:1-62.
152. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 1984;53:849-55. (Pubitemid 14154705)
153. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999;99:2138-43. (Pubitemid 29196798)
154. Ihling C, Szombathy T, Nampoothiri K, et al. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999;82:286-93. (Pubitemid 29429599)
155. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 2003;108(Suppl 1):II329-34. (Pubitemid 37099977)
156. Schmid FX, Bielenberg K, Schneider A, et al. Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. Eur J Cardiothorac Surg 2003;23:537-43. (Pubitemid 36411879)
157. de Sa M, Moshkovitz Y, Butany J, et al. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the ross procedure. J Thorac Cardiovasc Surg 1999;118:588-94.
158. Agozzino L, Ferraraccio F, Esposito S, et al. Medial degeneration does not involve uniformly the whole ascending aorta: morphological, biochemical and clinical correlations. Eur J Cardiothorac Surg 2002;21:675-82. (Pubitemid 34257955)
159. Collins MJ, Dev V, Strauss BH, et al. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases. J Clin Pathol 2008;61:519-23. (Pubitemid 351518238)
160. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991:352:337-9. (Pubitemid 21912353)
161. Bauer M, Pasic M, Meyer R, et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann Thorac Surg 2002;74:58-62. (Pubitemid 34734646)
162. Parai JL, Masters RG, Walley VM, et al. Aortic medial changes associated with bicuspid aortic valve: myth or reality? Can J Cardiol 1999;15:1233-8. (Pubitemid 30006762)
163. McKusick VA, Logue RB, Bahnson HT. Association of aortic valvular disease and cystic medial necrosis of the ascending aorta; report of four instances. Circulation 1957;16:188-94.
164. McKusick VA. Association of congenital bicuspid aortic valve and Erdheim's cystic medial necrosis. Lancet 1972;1:1026-7.
165. Fedak PW, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900-4. (Pubitemid 34925320)
166. Fedak PW, de Sa MP, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 2003;126:797-806. (Pubitemid 37151966)
167. Ikonomidis JS, Jones JA, Barbour JR, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg 2007;133:1028-36. (Pubitemid 46435954)
168. Jones JA, Stroud RE, Kaplan BS, et al. Differential protein kinase C isoform abundance in ascending aortic aneurysms from patients with bicuspid versus tricuspid aortic valves. Circulation 2007;116(Suppl):I144-9. (Pubitemid 47480783)
169. Boyum J, Fellinger EK, Schmoker JD, et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004;127:686-91. (Pubitemid 38316173)
170. Burke A, Virmani R. Sarcomas of the great vessels: a clinicopathologic study. Cancer 1993;71:1761-73.
171. Brocheriou I, Quillard A, Gatecel C, et al. An unusual primary vascular tumor: intimal sarcoma of the pulmonary artery. Ann Pathol 2000;20:69-72. (Pubitemid 30070538)
172. Salm R. Primary fibrosarcoma of aorta. Cancer 1972;29:73-83.
173. Brodowsky W. Primares sarkom der aorta thoracica mit verbreitung des neugebildes in der unteren koper helfte. Iber Leist Fortsckr Ges Med 1873;8:243-6.
174. Das AK, Kumar J, Reddy KS, et al. Primary tumors of the aorta. Ann Thorac Surg 1996;62:1526-8. (Pubitemid 26383572)
175. Seelig MH, Klingler PJ, Oldenburg WA, et al. Angiosarcoma of the aorta: report of a case and review of the literature. J Vasc Surg 1998;28:732-7. (Pubitemid 28481233)
176. Kwon TW, Kim DK, Kim GE, et al. Sarcoma of the abdominal aorta involving marginal arteries of the small intestine: a case report. Ann Vasc Surg 2003;19:719-23.
177. Becquemin JP, Lebbe CC, Saada F, et al. Sarcoma of the aorta: report of a case and review of the literature. Anna Vasc Surg 1988;2:225-30.
178. Bonhner H, Luther B, Braunstein S, et al. Primary malignant tumors of the aorta: clinical presentation, treatment, and course of different entities. J Vasc Surg 2003;38:1430-3. (Pubitemid 37517681)
179. Chiche L, Mongre'dien B, Brocheriou I, et al. Primary tumors of the thoracoabdominal aorta: surgical treatment of 5 patients and review of the literature. Ann Vasc Surg 2003;17:354-64. (Pubitemid 37193175)
180. Chataigner O, Mussot S, Fadel E, et al. Two cases of intra-pericardial tumors arising from the ascending aorta in adults. Eur J Cardiothorac Surg 2007;32:174-5. (Pubitemid 46874979)
181. Luthringer DJ, Virmani R, Weiss SW, et al. A distinctive cardiovascular lesion resembling histiocytoid (epithelioid) hemangioma. Am J Surg Pathol 1990;14:993-1000.
182. Melato M, Costantinides F, Pandullo C, et al. Masson's pseudoangiosarcoma, alias intravascular papillary endothelial hyperplasia, in dissecting aortic aneurysm caused by cystic medionecrosis. Cardiovasc Pathol 2001;10:247-9. (Pubitemid 32982886)
183. Sebenik M, Ricci A, Di Pasquale B, et al. Undifferentiated intimal sarcoma of large systemic blood vessels: report of 14 cases with immunohistochemical profile and review of the literature. Am J Surg Pathol 2005;29:1184-93. (Pubitemid 41232991)
184. Fletcher CDM, Unn KK, Mertens F. WHO classification of tumors: pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press 2002.
185. Davierwala P, David T, Butany J. A large lipoma of the ascending aorta. Ann Thorac Surg 2004;77:1079-80. (Pubitemid 38271097)
186. Akiyama K, Nakata K, Negishi N, et al. Intimal sarcoma of the thoracic aorta; clinical-course and autopsy finding. Ann Thorac Cardiovasc Surg 2005;11:135-8.
187. Fonseca JL, Fernandez-Valderrama I, Gesto R, et al. Malignant fibrous histiocitoma, of the aorta complicated by anuria. Ann Vasc Surg 1992;6:164-7.
188. Rudd R, Fair KP, Patterson JW. Aortic angiosarcoma presenting with cutaneous metastasis: case report and review of the literature. J Am Acad Dermatol 2000;43:930-3.
189. Franke S, Thalheimer A, Fein M, et al. Intimal angiosarcoma of the aorta: report of a case and review of the literature. J Vasc Surg 2004;40:548-53. (Pubitemid 39165033)
190. Mandelstamm M, Uber primare Neubildungen des Herzen. Virchows Arch A 1923;245:43-54.
191. Hoffmeier A, Semik M, Fallenberg EM, et al. Leiomyosarcoma of the pulmonary artery - a diagnostic chameleon. Eur J Cardiothorac Surg 2001;20:1049-51. (Pubitemid 33042420)
192. Nonomura A, Kurumaya H, Kono N, et al. Primary pulmonary artery sarcoma. Report of two autopsy cases studied by immunohistochemistry and electron microscopy, and review of 110 cases reported in the literature. Acta Pathol Jpn 1988;38:883-96.
193. Miura S, Meirmanova S, Nakashima M, et al. Intimal sarcoma of the pulmonary artery: report of an autopsy case. Pathol Res Pract 2005;201:469-74. (Pubitemid 41093726)
194. Fraire AE, Dail DH. Mesenchymal tumors, Part II: Tumors of hamartomatous, lipomatous, neural and vascular origin. In: Tomashefsky JF Jr, Cagle FT, Farver CF, et al., eds. Dail and Hammar's Pulmonary Pathology. Vol. II. "Neoplastic Lung Disease". Third ed. Springer Science - Business Media, LLC 2008, pp. 462-99.
195. Dornas AP, Campos FT, Rezende CJ, et al. Intimal sarcoma of the pulmonary artery: a differential diagnosis of chronic pulmonary thromboembolism. J Bras Pneumol 2009;35:814-8.
196. Cox J.E. Chiles C. Aquino SL, et al. Pulmonary artery sarcomas: a review of clinical and radiologic features. J Comput Assist Tomogr 1997;21:750-5.
197. Walles T, Macchiarini P. Clinical-pathologic conference in general thoracic surgery: Pulmonary artery fibrohistiocytic tumor in a child. J Thorac Cardiovas Surg 2004;128:319-22. (Pubitemid 38969818)
198. McGlennen RC, Manivel JC, Stanley SJ, et al. Pulmonary artery trunk sarcoma: a clinicopathologic, ultrastructural, and immunohistochemical study of four cases. Mod Pathol 1989;2:486-94.
199. Ramos SG, Salvattia LGC, Cipriano FG, et al. Pulmonary artery sarcoma and chronic thromboembolism. Pathol Res Pract 2008;204:139-41. (Pubitemid 351189054)
200. Malone R, Kerr K, Kavanah M, et al. Primary leiomyosarcoma of the abdominal aorta. J Vasc Surg 1996;24:487-93. (Pubitemid 26349817)
201. Astudillo L, Cron C, Gomez-Brouchetc A, et al. Angiosarcoma of the aorta. Rev med Interne 2007;28:718-20.
202. Karamlou T, Li MK, Williamson WK, et al. Angiosarcoma of the thoracoabdominal aorta presenting with systemic hypertension, anemia, and visceral ischemia. Ann Vasc Surg 2008;22:459-64.
203. Defawe OD, Thiry A, Lapiere CM, et al. Primary sarcoma of an abdominal aortic aneurysm. Abdom Imaging 2006;31:117-9. (Pubitemid 43081650)
204. Brylka D, Demos TC., Pierce K. Primary angiosarcoma of the abdominal aorta: a case report and literature review (aortic angiosarcoma). Abdom Imaging 2009;34:239-42.
205. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two dimensional echocardiographic aortic root dimension in normal children and adults. Am J Cardiol 1989, 44:507-12. (Pubitemid 19214582)
206. Agozzino L, De Vivo F, Falco A, et al. Non inflammatory aortic root disease and floppy aortic valve as cause of aortic regurgitation: a clinico-morphologic study. Int J Cardiol 1994;45:129-34. (Pubitemid 24192348)
207. Lopez-Candales A, Holmes DR, Liao S, et al. Decreased vascular smooth muscle density in medial degeneration of human abdominal aortic aneurysm. Am J Pathol 1997;150:993-1007. (Pubitemid 27106171)
208. Disabella E, Grasso M, Marziliano N, et al. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Eur J Hum Genet 2006;14:34-8. (Pubitemid 43019081)
209. Ferraraccio F, Esposito S, Sante P, et al. Scanning electron microscopy of aortic medial changes in aortic ascending dilatation. Ultrastruct Pathol 2004, 28:137-40. (Pubitemid 38901559)
210. Della Corte A, De Santo LS, Montagnani S, et al. Spatial pattern of protein matrix expression in dilated ascending aorta with aortic regurgitation, congenital bicuspid aortic valve, Marfan's syndrome. J Heart Valve Dis 2006;15:20-7. (Pubitemid 43180521)
211. Farina A, Chambery A, Esposito S, et al. Proteomic profilinig of medial degeneration in human ascending aorta. Clin Biochem 2010;43:387-96.